secwatch.observer — SEC 8-K summary
======================================

Issuer:     ADMA BIOLOGICS, INC. (ADMA)
CIK:        0001368514
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001140361-24-001198
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ADMA Biologics furnishes January 2024 corporate presentation; no specific financial or operational updates disclosed
--------------------------------------------------------------------------------

- Filing furnishes a corporate presentation under Item 7.01 Regulation FD.
- Presentation titled 'Realizing the Potential of Specialty Biologics with Groundbreaking Immunotechnology'.
- No earnings, guidance, or material business developments provided in the exhibit.
- Presentation is available on ADMA's website under Investors section.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124001198/0001140361-24-001198-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1368514/000114036124001198/ef20018277_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-001198

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer